VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | UKALL2011: ABL-class fusions & TKIs

Anthony Moorman, PhD, Newcastle University, Newcastle, UK discusses preliminary data from UKALL2011, focussing on ABL-class fusion acute lymphoblastic leukemia (ALL) and the use of tyrosine kinase inhibitors (TKIs). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter